John Theurer Cancer Center

January 14, 2022

Oral decitabine, an oral fixed-dose of combination decitabine and CDA inhibitor cedazuridine, is an FDA-approved therapy for patients with lower-risk myelodysplastic syndromes.

January 02, 2022

The chair of the Institute of Pain and Palliative Care explains how the holistic approach of palliative care makes it a unique treatment modality.

December 24, 2021

The chair of the Institute of Pain and Palliative Care explains how patients with cancer may improve their treatment outcomes with palliative care.

November 19, 2021

Joe Contreras, MD, chair of the Institute of Pain and Palliative Medicine, explains how some common misconceptions may be hindering patients from receiving potentially outcome-improving palliative care.

November 15, 2021

For National Hospice and Palliative Care Awareness Month, Joe Contreras, MD, spoke to Oncology Nursing News® about some common misconceptions between the 2 and how oncology nurses can more effectively speak with their patients about palliative care.